Great that LeMaitre Vascular see a good future for Adapt products.
- Forums
- ASX - By Stock
- AVR
- Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular, page-19
-
- There are more pages in this discussion • 271 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.50 |
Change
-0.050(0.27%) |
Mkt cap ! $363.6M |
Open | High | Low | Value | Volume |
$18.80 | $19.15 | $18.39 | $116.8K | 6.276K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4 | $18.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.50 | 90 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4 | 18.350 |
1 | 500 | 18.340 |
2 | 452 | 18.330 |
1 | 1000 | 18.320 |
1 | 300 | 18.200 |
Price($) | Vol. | No. |
---|---|---|
18.500 | 90 | 1 |
18.670 | 725 | 1 |
18.680 | 35 | 1 |
18.700 | 110 | 1 |
18.730 | 16 | 2 |
Last trade - 14.59pm 28/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online